ITGB3 and neoplasm: Using an in situ IHC approach, we confirmed that the CD61+ TILs (identified by CD61+CD103+CD8+ colocalized cells) were significantly present at higher frequency within tumor islets compared to the CD61− TILs (identified by CD61−CD103+CD8+ colocalized cells; Fig. 5e).